Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


02.06.2025

1 Am J Case Rep
2 Ann Surg Oncol
1 Appl Radiat Isot
1 Arch Public Health
3 Asian Pac J Cancer Prev
1 Bioengineering (Basel)
1 Biomol Biomed
2 BMC Cancer
1 BMC Complement Med Ther
1 BMC Infect Dis
1 BMC Med Inform Decis Mak
1 BMC Med Res Methodol
1 BMC Microbiol
3 BMC Public Health
2 BMC Womens Health
1 Br J Cancer
1 Cancer Causes Control
1 Cancer Lett
1 Cancer Med
1 Cancer Prev Res (Phila)
1 Cancer Treat Rev
2 Cell Signal
1 Ceska Gynekol
1 Comput Med Imaging Graph
1 Cureus
1 Discov Med
4 Discov Oncol
1 Eur J Cancer
1 Front Cell Infect Microbiol
1 Front Genet
1 Front Immunol
1 Front Oncol
1 Front Reprod Health
2 Gynecol Oncol
2 Healthcare (Basel)
1 Hum Vaccin Immunother
1 In Silico Pharmacol
1 Indian J Med Microbiol
2 Int J Environ Res Public Health
2 Int J Gynecol Cancer
4 Int J Mol Sci
1 Int J Nanomedicine
1 J Biophotonics
1 J Cancer Policy
2 J Clin Med
3 J Low Genit Tract Dis
1 J Med Internet Res
1 J Med Screen
2 J Med Virol
1 J Minim Invasive Gynecol
4 J Obstet Gynaecol Res
1 Lancet Glob Health
2 Life Sci
1 Med Phys
1 Medicina (Kaunas)
2 Medicine (Baltimore)
1 Microorganisms
1 Mol Cell Endocrinol
1 Nanomaterials (Basel)
1 Nat Prod Res
1 NPJ Precis Oncol
1 Obstet Gynecol Int
1 Obstet Gynecol Sci
2 Oncol Lett
1 Oncologist
1 Oxf Med Case Reports
1 PeerJ
1 Phys Med Biol
1 PLoS One
1 Prev Med
1 Prim Care
1 Rev Panam Salud Publica
3 Sci Rep
1 Support Care Cancer
1 Technol Cancer Res Treat
1 Virol J
1 Women Health


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Case Rep

  1. GUO H, Wu H, Li J, Li R, et al
    Neurological and Cardiac Adverse Events in Cervical Cancer Treatment: A Case of Postoperative Sintilimab-Induced Encephalitis and Myocarditis.
    Am J Case Rep. 2025;26:e947730.
    PubMed         Abstract available


    Ann Surg Oncol

  2. CHEN Q, Deng D, Zhu H, Li S, et al
    Integrative Analysis of Bulk Multiomics and Single-Cell Transcriptomics Elucidates Age-Related Molecular Landscape Alterations in Cervical Cancer.
    Ann Surg Oncol. 2025 May 26. doi: 10.1245/s10434-025-17464.
    PubMed         Abstract available

  3. PEI K, Li D, Xi M
    Simple Hysterectomy as a Viable Alternative to Radical Hysterectomy for Early-Stage Cervical Cancer: A Population-Based Cohort Study.
    Ann Surg Oncol. 2025 May 24. doi: 10.1245/s10434-025-17520.
    PubMed         Abstract available


    Appl Radiat Isot

  4. XIE H, Liu J, Sun L, Xie T, et al
    Study of the application of the deformed dose summation (DDS) method in brachytherapy for advanced cervical cancer and analysis of regional dosing in recurrent cervical cancer.
    Appl Radiat Isot. 2025;224:111945.
    PubMed         Abstract available


    Arch Public Health

  5. MAHITI GR, Adam J, Luoga P
    Prevalence and determinants of cervical cancer screening among women aged 15-49 years in Tanzania: analysis of demographic and health survey 2022.
    Arch Public Health. 2025;83:135.
    PubMed         Abstract available


    Asian Pac J Cancer Prev

  6. GUPTA S, Dey A, Kundu S, Sinha Gupta S, et al
    Barriers to Cervical Cancer Screening in India: Insights from National Family Health Survey-5 Data.
    Asian Pac J Cancer Prev. 2025;26:1853-1861.
    PubMed         Abstract available

  7. GANGWAR A, Raghuvanshi S, Bhalla S, Agarwal P, et al
    Quantification of Circulating HPV DNA as a Biomarker for Cervical pre-cancer and cancer: A Pilot Study.
    Asian Pac J Cancer Prev. 2025;26:1681-1687.
    PubMed         Abstract available

  8. OGONCHO IM, Wakasiaka S, Mageto IG, Chege M, et al
    Effect of a Nurse-Led Educational Intervention on the Knowledge, Perceptions and Uptake of Cervical Cancer Screening among HIV-Infected Women in Kenya.
    Asian Pac J Cancer Prev. 2025;26:1591-1597.
    PubMed         Abstract available


    Bioengineering (Basel)

  9. ALZAKARI SA, Alhussan AA, Towfek SK, Metwally M, et al
    Cervical Cancer Detection Using Deep Neural Network and Hybrid Waterwheel Plant Optimization Algorithm.
    Bioengineering (Basel). 2025;12:478.
    PubMed         Abstract available


    Biomol Biomed

  10. PEZER NALETILIC M, Tomic K, Katic K, Gatalica Z, et al
    The immunotherapy breakthroughs in cervical cancer: Focus on potential biomarkers and further therapy advances.
    Biomol Biomed. 2025 May 22. doi: 10.17305/bb.2025.12597.
    PubMed         Abstract available


    BMC Cancer

  11. YE Y, Chen Y, Pan J, Li P, et al
    Integrating SEResNet101 and SE-VGG19 for advanced cervical lesion detection: a step forward in precision oncology.
    BMC Cancer. 2025;25:963.
    PubMed         Abstract available

  12. WANG Y, Lin AY, Wang DD, Lin PP, et al
    In situ phenotypic and karyotypic co-detection of aneuploid TCs and TECs in cytological specimens with abnormal cervical screening results.
    BMC Cancer. 2025;25:945.
    PubMed         Abstract available


    BMC Complement Med Ther

  13. HESHAM W, Elzayat EM, Hosney M, Abo-Elghiet F, et al
    Chemical profiling and anticancer activity of Alnus incana dichloromethane fraction on HeLa cells via cell cycle arrest and apoptosis.
    BMC Complement Med Ther. 2025;25:189.
    PubMed         Abstract available


    BMC Infect Dis

  14. DING H, Jin H, Tang Y
    HPV genotype distribution and cervical lesions in Chongqing: a comprehensive analysis of 229,770 females (2015?2023).
    BMC Infect Dis. 2025;25:760.
    PubMed         Abstract available


    BMC Med Inform Decis Mak

  15. ARAGE FG, Tadese ZB, Taye EA, Tsegaw TK, et al
    Cervical cancer screening uptake and its associated factor in Sub-Sharan Africa: a machine learning approach.
    BMC Med Inform Decis Mak. 2025;25:197.
    PubMed         Abstract available


    BMC Med Res Methodol

  16. WEBER A, Voko Z, Kiss Z, Szatmari I, et al
    The impact of life tables on age standardized net survival of real-life example databases.
    BMC Med Res Methodol. 2025;25:145.
    PubMed         Abstract available


    BMC Microbiol

  17. DU J, Tan T, Yu Y, Wang H, et al
    The mechanism of ECT1/E6E7 cervical intraepithelial neoplasia cells regulated by Acinetobacter lwoffii through circ-LDHA/HMGB1.
    BMC Microbiol. 2025;25:326.
    PubMed         Abstract available


    BMC Public Health

  18. TOYOSHIMA M, Takizawa A, Kubonoya K, Kurose K, et al
    The impact of medical expert-led sex education on sexual health knowledge among Japanese junior high school students: a quantitative study.
    BMC Public Health. 2025;25:1971.
    PubMed         Abstract available

  19. MOUCHERAUD C, Chibaka S, Golub G, Kalande P, et al
    Factors associated with cervical cancer screening: results from cross-sectional surveys in Kenya and Malawi.
    BMC Public Health. 2025;25:1956.
    PubMed         Abstract available

  20. MALEKI A, Ahadinezhad B, Alizadeh A, Khosravizadeh O, et al
    Barriers and facilitators of pap-smear test uptake in Asia: a systematic review.
    BMC Public Health. 2025;25:1961.
    PubMed         Abstract available


    BMC Womens Health

  21. XU S, Jiang T, Mao X, Cai L, et al
    Assessment of risk factors for high-grade cervical or endometrial lesions to triage women with AGC-FN: a retrospective study.
    BMC Womens Health. 2025;25:260.
    PubMed         Abstract available

  22. APPIAH RS, Boakye K, Appiah G, Aidoo AA, et al
    Rural-urban variations in cervical cancer screening uptake among women in Ghana: Evidence from the 2022 Ghana Demographic and Health Survey.
    BMC Womens Health. 2025;25:255.
    PubMed         Abstract available


    Br J Cancer

  23. SU H, Jin X, Kong L, You Y, et al
    The triage role of cytological DNA methylation in women with non-16/18, specifically genotyping high-risk HPV infection.
    Br J Cancer. 2025 Apr 10. doi: 10.1038/s41416-025-03005.
    PubMed         Abstract available


    Cancer Causes Control

  24. DELIKTAS DEMIRCI A, Avci M, Kabukcuoglu K
    Fear of cancer levels of women who applied cervical cancer screening: a cross-sectional study of the effects of health beliefs related to cervical cancer and Pap-Smear test.
    Cancer Causes Control. 2025 May 25. doi: 10.1007/s10552-025-02008.
    PubMed         Abstract available


    Cancer Lett

  25. GONG Y, Zhang W, Wang X, Zheng S, et al
    A previously uncharacterized role of TAp73 in ferroptosis by modulating oxidative homeostasis in cervical cancer.
    Cancer Lett. 2025;627:217815.
    PubMed         Abstract available


    Cancer Med

  26. BAVOR C, Saunders T, Wolfe M, Smith MA, et al
    'I Don't Think There Is a One-Size-Fits-All': A Qualitative Study Exploring Healthcare Professional and Service Provider Perspectives of Using Innovative Models of Cervical Screening to Improve Equitable Access to Self-Collection.
    Cancer Med. 2025;14:e70981.
    PubMed         Abstract available


    Cancer Prev Res (Phila)

  27. PALMIERI L, Zamuner FT, de Lima DG, Gosala K, et al
    CervicalMethDx: a precision DNA methylation test to identify risk of high-grade intraepithelial lesions in cervical cancer screening algorithms.
    Cancer Prev Res (Phila). 2025 May 29. doi: 10.1158/1940-6207.CAPR-25-0029.
    PubMed         Abstract available


    Cancer Treat Rev

  28. ANDRADE MO, Al-Alam OCM, Kim HJS, Batista JPT, et al
    Induction chemotherapy followed by chemoradiotherapy for locally advanced cervical cancer: A systematic review and meta-analysis.
    Cancer Treat Rev. 2025;138:102959.
    PubMed         Abstract available


    Cell Signal

  29. JING Q, Chen Q, Wang G, Wu T, et al
    LINC02593 impedes cell senescence via COP1-mediated p53 degradation in cervical cancer.
    Cell Signal. 2025 May 27:111907. doi: 10.1016/j.cellsig.2025.111907.
    PubMed         Abstract available

  30. BAI H, Wei X, Yan X, Wei S, et al
    GRHL3 specifically initiated by the TP63 transcription factor promotes the metastasis of squamous cell carcinogenesis.
    Cell Signal. 2025;132:111794.
    PubMed         Abstract available


    Ceska Gynekol

  31. SLADKOVA P, Brtnicky T, Hormandlova L, Polkova M, et al
    Occupational therapy in oncogynecology - a pilot study.
    Ceska Gynekol. 2025;90:113-121.
    PubMed         Abstract available


    Comput Med Imaging Graph

  32. GU Y, Guo H, Zhang J, Gao Y, et al
    MFFUNet: A hybrid model with cross-attention-guided multi-feature fusion for automated segmentation of organs at risk in cervical cancer brachytherapy.
    Comput Med Imaging Graph. 2025;124:102571.
    PubMed         Abstract available


    Cureus

  33. YARDEN NT, Sport C, Bale C, Mukhopadhyay N, et al
    The Impact of Split Radiation Therapy on the Management of Locally Advanced Cervical Cancer in Central Virginia.
    Cureus. 2025;17:e83130.
    PubMed         Abstract available


    Discov Med

  34. CAO G, Wei Y, Ma X
    Investigating Anti-Tumor Effects of Irisin in Cervical Cancer Cells: Cell Viability, Migration, and Tumor-Associated Macrophage Polarization.
    Discov Med. 2025;37:946-956.
    PubMed         Abstract available


    Discov Oncol

  35. XU X, Huang Y, Wei W, Lin Z, et al
    To explore the molecular mechanisms and shared genetic characteristics of rheumatoid arthritis and cervical cancer based on multiple omics and clinical samples.
    Discov Oncol. 2025;16:945.
    PubMed         Abstract available

  36. ZHANG Z, Fu F, Zhuang S
    Mendelian randomization reveals limited causal effects of genetic variants on cervical cancer risk: insights from immune cell populations.
    Discov Oncol. 2025;16:944.
    PubMed         Abstract available

  37. PANG C, Long X, Luo Y, Luo Y, et al
    Exploring program-cell death patterns to predict prognosis and sensitivity of cervical cancer immunotherapy via multi-omics analysis and clinical samples.
    Discov Oncol. 2025;16:940.
    PubMed         Abstract available

  38. PARVIZI M, Vaezi M, Jeddi F, Bakhshandeh M, et al
    The role and diagnostic value of deregulated miRNAs in cervical cancer.
    Discov Oncol. 2025;16:922.
    PubMed         Abstract available


    Eur J Cancer

  39. WANG H, Wang N
    Letter Re: Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial.
    Eur J Cancer. 2025 May 19:115515. doi: 10.1016/j.ejca.2025.115515.
    PubMed        


    Front Cell Infect Microbiol

  40. GUO Y, Xiao Y, Zhang C, Wang Y, et al
    The intratumoral microbiota heterogenicity is related to the prognosis and tumorigenesis of cervical cancer.
    Front Cell Infect Microbiol. 2025;15:1574511.
    PubMed         Abstract available


    Front Genet

  41. WEI J, Wang M, Wu Y
    Comprehensive analysis of mRNA and lncRNA expression for predicting lymph node metastasis in cervical cancer: a novel seven-gene signature approach.
    Front Genet. 2025;16:1524821.
    PubMed         Abstract available


    Front Immunol

  42. KOUHEN F, El Ghanmi A, Inghaoun H, Miftah H, et al
    The promise of PD1/PDL1 targeted immunotherapy in locally advanced cervical cancer: a game-changer for patients outcome?
    Front Immunol. 2025;16:1573576.
    PubMed         Abstract available


    Front Oncol

  43. YAO Y, Yang X, Fu Y, Zhang Y, et al
    Immunological features of various molecular subtypes of cervical cancer and their prognostic implications in the context of disulfidptosis.
    Front Oncol. 2025;15:1574911.
    PubMed         Abstract available


    Front Reprod Health

  44. NYAMBE A, Lubeya MK
    Editorial: Cervical cancer awareness - volume I: screening, vaccines, and prevention.
    Front Reprod Health. 2025;7:1579018.
    PubMed        


    Gynecol Oncol

  45. ACOSTA U, Bebia V, Torne A, Carreras-Dieguez N, et al
    Topographic mapping of pelvic and aortic lymph node metastases in stage IIIC1r locally advanced cervical cancer: A retrospective study by the Spain-GOG group.
    Gynecol Oncol. 2025;198:49-54.
    PubMed         Abstract available

  46. LEE JY, Boonyapipat S, Yuan G, Kim HS, et al
    AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab plus tislelizumab and tislelizumab alone in patients with previously treated recurrent or metastatic cervical cancer.
    Gynecol Oncol. 2025;198:25-32.
    PubMed         Abstract available


    Healthcare (Basel)

  47. USSAI S, Seyidov T, Khomasuridze T, On Behalf Of The Regional Alliance Group Of Experts On Hpv Vaccination, et al
    Regional Alliance for Cervical Cancer Prevention in Eastern Europe and Central Asia: Progressing Towards the Target 1 of the Global Strategy for Cervical Cancer Elimination.
    Healthcare (Basel). 2025;13:1209.
    PubMed         Abstract available

  48. TUNG HJ, Schwarzschild G, Gopep N, Yeh MC, et al
    Cervical Cancer Screening After Menopause.
    Healthcare (Basel). 2025;13:1157.
    PubMed         Abstract available


    Hum Vaccin Immunother

  49. LI X, Zheng J, Zhang Z, Fu D, et al
    An investigation of HPV vaccination willingness and influential factors among college students in Beijing based on the BeSD framework and evaluation of momentary intervention effect.
    Hum Vaccin Immunother. 2025;21:2505354.
    PubMed         Abstract available


    In Silico Pharmacol

  50. SUNDAY UE, Stephanie MI, Otuonye F, Oluwadamilola D, et al
    Computational investigation of stigmasterol as a potential therapeutic agent for cervical cancer: insights from density functional theory (DFT) and molecular docking studies.
    In Silico Pharmacol. 2025;13:77.
    PubMed         Abstract available


    Indian J Med Microbiol

  51. SUN C, Diao H, Zhang X, Han Z, et al
    Study on human papillomavirus (HPV) infection, typing, peripheral blood immune factor expression and vaginal microenvironment balance in cervical cancer screening population.
    Indian J Med Microbiol. 2025 May 26:100883. doi: 10.1016/j.ijmmb.2025.100883.
    PubMed         Abstract available


    Int J Environ Res Public Health

  52. CHEPKORIR J, Perrin N, Kivuti-Bitok L, Gallo JJ, et al
    Barriers and Opportunities for HPV Self-Sampling in Underserved Rural Communities: Insights from a Mixed Methods Study.
    Int J Environ Res Public Health. 2025;22:783.
    PubMed         Abstract available

  53. SMAIL L
    Quality of Life of Emirati Women with Cervical Cancer Using EORTC QLQ-30 and CX24: A First Look in the UAE.
    Int J Environ Res Public Health. 2025;22:671.
    PubMed         Abstract available


    Int J Gynecol Cancer

  54. KACPERCZYK-BARTNIK J, El Hajj H, Toth I, Bizzarri N, et al
    Declaration on cervical cancer elimination: literature review and perspectives from early-career clinicians.
    Int J Gynecol Cancer. 2025;35:101902.
    PubMed         Abstract available

  55. VILLEGAS SANCHEZ S, Ramirez Cantillo S, Hernandez Aramburo PM, Hernandez JM, et al
    Cervical cancer prevention in Colombian indigenous communities, a project by Acacia de Vida Foundation.
    Int J Gynecol Cancer. 2025 Jan 9:101623. doi: 10.1016/j.ijgc.2024.101623.
    PubMed        


    Int J Mol Sci

  56. TOMAZIU-TODOSIA ANTON E, Anton GI, Scripcariu IS, Dumitrascu I, et al
    Oxidative Stress, Inflammation, and Antioxidant Strategies in Cervical Cancer-A Narrative Review.
    Int J Mol Sci. 2025;26:4961.
    PubMed         Abstract available

  57. CHAI Y, Yu S, Lin G, Luo C, et al
    Polyphyllin I Inhibits the Metastasis of Cervical Cancer Through the Regulation of the beta-Catenin Signaling Pathway.
    Int J Mol Sci. 2025;26:4630.
    PubMed         Abstract available

  58. MIRANDA CAN, Souza ATB, Soares AKMDC, Bernardes-Oliveira E, et al
    Apoptosis and G2/M Phase Cell Cycle Arrest Induced by Alkaloid Erythraline Isolated from Erythrina velutina in SiHa Cervical Cancer Cell.
    Int J Mol Sci. 2025;26:4627.
    PubMed         Abstract available

  59. ALI H, Rasool S, Saidu MB, German P, et al
    Characterization of the Antiproliferative and Antimetastatic Properties of Centrapalus pauciflorus Meroterpenoid Centrapalus Coumarin F.
    Int J Mol Sci. 2025;26:4489.
    PubMed         Abstract available


    Int J Nanomedicine

  60. HE Z, Zheng X, Liu R, Zhao K, et al
    Recent Advances in HPV Detection: From Traditional Methods to Nanotechnology and the Application of Quantum Dots.
    Int J Nanomedicine. 2025;20:6333-6356.
    PubMed         Abstract available


    J Biophotonics

  61. NAYAK S, Deo BS, Pal M, Panigrahi PK, et al
    Empirical Mode Decomposition and Grassmann Manifold-Based Cervical Cancer Detection.
    J Biophotonics. 2025 May 28:e202400584. doi: 10.1002/jbio.202400584.
    PubMed         Abstract available


    J Cancer Policy

  62. DORJI N, Dorji T, Dorjey Y, Tshering S, et al
    Bhutan achieves the 90-70-90 targets on the path to elimination of cervical cancer: Experience, challenges and way forward.
    J Cancer Policy. 2025;44:100596.
    PubMed         Abstract available


    J Clin Med

  63. MANEA E, Anghel B, Stanescu AD, Rata AM, et al
    Adaptive Target Volume and Dosimetry in Image-Guided Radiotherapy for Cervical Cancer.
    J Clin Med. 2025;14:3418.
    PubMed         Abstract available

  64. ADAMS J, Wingels A, Amir-Kabirian C, Jeschke JK, et al
    The Predictive Value of Preoperative Histological Risk Factors in Early Cervical Cancer.
    J Clin Med. 2025;14:3277.
    PubMed         Abstract available


    J Low Genit Tract Dis

  65. MARCUS JZ, Nelson E, Linder M, Chelmow DP, et al
    ASCCP Clinical Consensus: Screening Recommendations for Clear Cell Adenocarcinomas in People Exposed to DES In Utero.
    J Low Genit Tract Dis. 2024;28:351-355.
    PubMed         Abstract available

  66. CHAWLA N, Marshall J, Dubinskaya A, Wakefield D, et al
    Knowledge of the Human Papillomavirus Vaccine and Willingness to Accept Vaccination in the Postpartum Period.
    J Low Genit Tract Dis. 2024;28:340-344.
    PubMed         Abstract available

  67. VIEIRA-BAPTISTA P, Costa M, Hippe J, Sousa C, et al
    Evaluation of Host Gene Methylation as a Triage Test for HPV-Positive Women-A Cohort Study.
    J Low Genit Tract Dis. 2024;28:326-331.
    PubMed         Abstract available


    J Med Internet Res

  68. MEHRA R, Ray A, Kumari A, Kaur A, et al
    Google Trends for the Human Papillomavirus Vaccine in India From 2010 to 2024: Infodemiological Study.
    J Med Internet Res. 2025;27:e69729.
    PubMed         Abstract available


    J Med Screen

  69. MARLOW L, Drysdale H, Waller J
    Attitudes towards being offered a choice of self-sampling or clinician sampling for cervical screening: A cross-sectional survey of women taking part in a clinical validation of HPV self-collection devices.
    J Med Screen. 2025;32:93-99.
    PubMed         Abstract available


    J Med Virol

  70. ZHOU Y, Liu J, Chen S, Pan W, et al
    Human Papillomavirus Genotyping and Viral Load as a Predictor of Cervical Lesions: A Prospective Study.
    J Med Virol. 2025;97:e70386.
    PubMed         Abstract available

  71. CHEN Z, Li H, Zhao J, Feng H, et al
    Human Papillomavirus Genotype Distribution and Viral Load in Relation to Cervical Disease Severity: A Retrospective Study of Outpatient Data in Beijing, China.
    J Med Virol. 2025;97:e70409.
    PubMed         Abstract available


    J Minim Invasive Gynecol

  72. HWANG JH, Kim B
    Postoperative Urinary Complications in Minimally Invasive Versus Abdominal Radical Hysterectomy: A Meta-Analysis With a Focus on Ureterovaginal Fistula.
    J Minim Invasive Gynecol. 2025;32:502-511.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  73. KURITA T, Yamamoto A, Hosoya T, Tsuchida M, et al
    Lack of knowledge, not vaccine hesitancy, is the main cause of low human papilloma virus vaccination rate among systemic lupus erythematosus patients in Japan after suspension of proactive recommendation: Analysis of a patients' survey.
    J Obstet Gynaecol Res. 2025;51:e16330.
    PubMed         Abstract available

  74. CEA GARCIA J, Rodriguez Jimenez I, Rios-Pena L, Rubio Rodriguez MC, et al
    A risk nomogram for assessing complications in patients undergoing surgical procedures for cervical cancer. Does baseline quality of life play a role?
    J Obstet Gynaecol Res. 2025;51:e16318.
    PubMed         Abstract available

  75. MINAKAWA T, Nozaki A, Nakajin T, Mitsube K, et al
    Concurrent chemoradiotherapy for advanced cervical cancer during second trimester pregnancy: A case report.
    J Obstet Gynaecol Res. 2025;51:e16326.
    PubMed         Abstract available

  76. LE DC, Pham TM, Quy PN, Hamanishi J, et al
    Premature mortality due to cervical and ovarian cancers in Japan, 2000 to 2020.
    J Obstet Gynaecol Res. 2025;51:e16327.
    PubMed         Abstract available


    Lancet Glob Health

  77. SHING JZ, Mashele S, Tsegaye AT, Da Costa Dias B, et al
    Changes in incidence of HPV-related cancers in South Africa (2011-21): a cross-sectional analysis of the South African National Cancer Registry.
    Lancet Glob Health. 2025;13:e1101-e1110.
    PubMed         Abstract available


    Life Sci

  78. MA X, Xu Z, Wang X, Sun S, et al
    Aberrant WDR5 promotes the progression of cervical cancer through the YAP1- CTGF pathway.
    Life Sci. 2025;376:123712.
    PubMed         Abstract available

  79. TU K, Luo Z, Yi L, Li Z, et al
    FoxM1 promotes the proliferation of cervical adenocarcinoma cells through transcriptional activation of FAM83D.
    Life Sci. 2025;374:123691.
    PubMed         Abstract available


    Med Phys

  80. LEI Y, Chao M, Yang K, Gupta V, et al
    A novel network architecture for post-applicator placement CT auto-contouring in cervical cancer HDR brachytherapy.
    Med Phys. 2025 May 25. doi: 10.1002/mp.17908.
    PubMed         Abstract available


    Medicina (Kaunas)

  81. KAZLAUSKAITE J, Zukiene G, Rudaitis V, Bartkeviciene D, et al
    The Vaginal Microbiota, Human Papillomavirus, and Cervical Dysplasia-A Review.
    Medicina (Kaunas). 2025;61:847.
    PubMed         Abstract available


    Medicine (Baltimore)

  82. LEE KE, Kim JA, Kim MJ, Lee HN, et al
    Cervical adenocarcinoma misdiagnosed as a nabothian cyst during pregnancy: A case report and review of the literatures.
    Medicine (Baltimore). 2025;104:e42336.
    PubMed         Abstract available

  83. WANG Y, Yin Y, Wei Z, Zhou N, et al
    A retrospective study on the relationship between delirium and long-term cognitive function in elderly women following cervical cancer surgery.
    Medicine (Baltimore). 2025;104:e42120.
    PubMed         Abstract available


    Microorganisms

  84. PAVELESCU LA, Mititelu-Zafiu NL, Mindru DE, Vladareanu R, et al
    Molecular Insights into HPV-Driven Cervical Cancer: Oncoproteins, Immune Evasion, and Epigenetic Modifications.
    Microorganisms. 2025;13:1000.
    PubMed         Abstract available


    Mol Cell Endocrinol

  85. BOSE S, Das S, Maity S, Raychaudhuri D, et al
    Androgen receptor plays critical role in regulating cervical cancer cell migration.
    Mol Cell Endocrinol. 2025;606:112583.
    PubMed         Abstract available


    Nanomaterials (Basel)

  86. ROSQVIST E, Niemela E, Liang S, Eriksson JE, et al
    Proliferation of Human Cervical Cancer Cells Responds to Surface Properties of Bicomponent Polymer Coatings.
    Nanomaterials (Basel). 2025;15:716.
    PubMed         Abstract available


    Nat Prod Res

  87. CAGNIN PEREIRA T, Cardoso LP, da Silva de Paiva W, Santos de Camargos L, et al
    Analysis of metabolic compounds and antitumorigenic effects of Albizia niopoides and Senegalia polyphylla leaves.
    Nat Prod Res. 2025;39:3140-3147.
    PubMed         Abstract available


    NPJ Precis Oncol

  88. XIA P, Zhou J, Shen R, Wang D, et al
    Deciphering the cellular and molecular landscape of cervical cancer progression through single-cell and spatial transcriptomics.
    NPJ Precis Oncol. 2025;9:158.
    PubMed         Abstract available


    Obstet Gynecol Int

  89. PATHAK P, Ghimire P, Chaudhary SK, Piya N, et al
    Awareness, Practice, and Barriers Regarding Cervical Cancer Screening Among Women of Kageshwori Manohara Municipality, Nepal.
    Obstet Gynecol Int. 2025;2025:5325540.
    PubMed         Abstract available


    Obstet Gynecol Sci

  90. ABRAR SS, Isa SAM, Hairon SM, Ismail MP, et al
    Recent Advances in Applications of Machine Learning in Cervical Cancer Research: A Focus on Prediction Models.
    Obstet Gynecol Sci. 2025 May 29. doi: 10.5468/ogs.25041.
    PubMed         Abstract available


    Oncol Lett

  91. LIAO H, Chang X, Hou X, Zhang F, et al
    Pancreatic metastasis from cervical cancer: A case report and literature review.
    Oncol Lett. 2025;30:349.
    PubMed         Abstract available

  92. PENG H, Xu N, Gao D, Tan H, et al
    Fan beam computed tomography-guided online adaptive external radiotherapy for cervical cancer achieves pathological complete response: A case report.
    Oncol Lett. 2025;30:344.
    PubMed         Abstract available


    Oncologist

  93. SAAD A, Taylor A, Felder S, Helpman L, et al
    De-escalating first-line treatment in stage IVB or recurrent cervical cancer: outcomes of immunotherapy alone and systemic review.
    Oncologist. 2025;30:oyaf096.
    PubMed         Abstract available


    Oxf Med Case Reports

  94. TJOKROPRAWIRO BA, Novitasari K, Ulhaq RA
    Torsion Giant ovarian cysts in a postmenopausal woman with cervical cancer.
    Oxf Med Case Reports. 2025;2025:omaf054.
    PubMed         Abstract available


    PeerJ

  95. SHAO J, Zhang C, Tang Y, He A, et al
    Sialyltransferase-related genes as predictive factors for therapeutic response and prognosis in cervical cancer.
    PeerJ. 2025;13:e19422.
    PubMed         Abstract available


    Phys Med Biol

  96. JIANG R, Madondo M, Zhang X, Shao Y, et al
    Deep learning-based applicator selection between Syed and T&O in high-dose-rate brachytherapy for locally advanced cervical cancer: a retrospective study.
    Phys Med Biol. 2025 May 29. doi: 10.1088/1361-6560.
    PubMed         Abstract available


    PLoS One

  97. SHI Y, Zhang L, Zhou Y, Liao X, et al
    A cross-sectional study of factors influencing sexual health among spouses of patients with cervical cancer.
    PLoS One. 2025;20:e0322141.
    PubMed         Abstract available


    Prev Med

  98. MCCLYMONT E, de Sanjose S, Garland SM, Moscicki AB, et al
    International Papillomavirus Society policy statement on human papillomavirus-based cervical cancer screening for women living with HIV.
    Prev Med. 2025;197:108314.
    PubMed         Abstract available


    Prim Care

  99. KENEALY BP, Lochner JE
    Cancer Screening in Women.
    Prim Care. 2025;52:233-248.
    PubMed         Abstract available


    Rev Panam Salud Publica

  100. HUANCA CHALLGUA C, Linander I, Goicolea I, Eid Rodriguez D, et al
    Geographical inequities in cervical cancer screening coverage in Bolivia: a spatial nationwide ecological study.
    Rev Panam Salud Publica. 2025;49:e44.
    PubMed         Abstract available


    Sci Rep

  101. ZHANG M, Zhang Q, Wang X, Peng X, et al
    Prediction of clinical stages of cervical cancer via machine learning integrated with clinical features and ultrasound-based radiomics.
    Sci Rep. 2025;15:18862.
    PubMed         Abstract available

  102. ZHANG M, Sit JWH, Choi KC, Chow KM, et al
    Effects of a theory driven and culturally tailored educational program on promoting cervical cancer screening in rural populations.
    Sci Rep. 2025;15:18540.
    PubMed         Abstract available

  103. NTONIFOR MM, Tazinkeng NN, Kemah BL, Claudia NE, et al
    Factors associated with parental hesitancy towards the human papillomavirus vaccine: a cross-sectional study.
    Sci Rep. 2025;15:18284.
    PubMed         Abstract available


    Support Care Cancer

  104. DETLEFSEN SS, Andersen DS, Knudsen AO, Nottrup TJ, et al
    Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study.
    Support Care Cancer. 2025;33:509.
    PubMed         Abstract available


    Technol Cancer Res Treat


  105. Retraction notice: "MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer".
    Technol Cancer Res Treat. 2025;24:15330338251343588.
    PubMed        


    Virol J

  106. KARIMI M, Parsania M, Motakef Kazemi N, Qomi M, et al
    Curcumin nanoemulsion suppresses HPV oncogenes and inhibits cervical cancer progression: in vitro and in vivo study.
    Virol J. 2025;22:165.
    PubMed         Abstract available


    Women Health

  107. SCHERER-QUENZER AC, Findeis J, Herbert SL, Buchel J, et al
    Evaluating the necessity of endocone resection during LLETZ: Impact of routine ECC and follow-up testing in predicting persistent/recurrent cervical dysplasia.
    Women Health. 2025;65:442-452.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.